MobiHealth News April 12, 2024
Trevor Dermody

The feature provides vibrotactile stimulation when a patient is experiencing freezing of gait, a common symptom of Parkinson’s disease.

Turkey-based digital health startup h2o therapeutics announced its new Apple Watch-enabled freezing of gait-cuing feature, dubbed Foggy, designed for Parkinson’s Disease patients has received FDA listing as a Class II medical device and is available via prescription.

According to the Parkinson’s Foundation, freezing of gait is a symptom of Parkinson’s Disease in which a patient experiences a temporary, involuntary inability to move. Freezing may also affect a person’s speech or other parts of the body.

h2o therapeutics is a company that deploys augmented reality, AI and mobile-based digital therapeutics. The company also offers an early-detection COVID-19 smartwatch system named Covie.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Medical Devices, Technology
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
Medical device cyber updates must consider patient safety
Open Source Healthcare – The Cure for Stagnant Medical Innovation
Stryker to sell US spinal implants business to investment firm
Samsung Medison Launches AI-Powered Ultrasound System, Z20

Share This Article